Interferon gamma is not required for recurrent herpetic stromal keratitis

Virology

Volumn 380, Issue 1, 2008, Pages 46-51

  Keadle, Tammie L ^a   Alexander, Diane E ^a   Leib, David A ^a   Stuart, Patrick M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Herpes simplex; Herpetic stromal keratitis; Inflammation; Interferon ; T cells; Viral reactivation

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEPHARITIS; C57BL 6 MOUSE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; IMMUNE RESPONSE; INCIDENCE; KNOCKOUT MOUSE; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RECURRENT VIRUS INFECTION; TEAR FILM; ULTRAVIOLET B RADIATION; VIRUS CONCENTRATION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; CORNEAL STROMA; HERPESVIRUS 1, HUMAN; INTERFERON TYPE II; KERATITIS, HERPETIC; MICE; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS; ULTRAVIOLET RAYS; VIRUS REPLICATION; VIRUS SHEDDING;

HERPES; MUS; SIMPLEXVIRUS;

EID: 52049120564     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.07.018     Document Type: Article

References (45)

1. Babu J.S., Kanangat S., and Rouse B.T. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J. Immunol. 154 (1995) 4822-4829
2. Banerjee K., Biswas P.S., and Rouse B.T. Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis. J. Interfer. Cytokin. Res. 27 (2007) 65-75
3. Bouley D.M., Kanangat S., Wire W., and Rouse B.T. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFNg Knockout mice. J. Immunol. 155 (1995) 3964-3971
4. Cantin E., Tanamachi B., and Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 73 (1999) 3418-3423
5. Cantin E., Tanamachi B., Openshaw H., Mann J., and Clarke K. Gamma interferon receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFNg ligand null mutant mice. J. Virol. 73 (1999) 5196-5200
6. Ellison A.R., Yang L., Voytek C., and Margolis T.P. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology 268 (2000) 17-28
7. Foster C.S., Tsai Y., Monroe J.G., Campbell R., Cestari M., Wetzig R., Knipe D., and Greene M.I. Genetic studies on murine susceptibility to herpes simplex keratitis. Clin. Immunol. Immunopathol. 40 (1986) 313-325
8. Ghiasi H., Cai S., Perng G.C., Nesburn A.B., and Wechsler S.L. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res. 45 (2000) 33-45
9. Gierasch W.W., Zimmerman D.L., Ward S.L., Vanheyningen T.K., Romine J.D., and Leib D.A. Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J. Virol. Methods 135 (2006) 197-206
10. He J., Ichimura H., Iida T., Minami M., Kobalyashi K., Kita M., Sotozono C., Tagawa Y.I., Iwakura Y., and Imanishi J. Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL/6 mice after corneal HSV-1 infection. J. Interfer. Cyto. Res. 19 (1999) 609-615
11. Hendricks R.L., Tumpey T.M., and Finnegan A. IFN-g and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 149 (1992) 3023-3028
12. Kaplan M.H. Stat4: a critical regulator of inflammation in vivo. Immunol. Res. 31 (2005) 231-242
13. Keadle T.L., and Stuart P.M. IL-10 ameliorates corneal disease in a mouse model of recurrent herpetic keratitis. Microbial Path. 38 (2005) 13-21
14. Keadle T.L., Laycock K.A., Miller J.K., Hook K.K., Fenoglio E.D., Francotte M., Slaoui M., Stuart P.M., and Pepose J.S. Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice. J.Inf. Dis 176 (1997) 331-338
15. Keadle T.L., Laycock K.A., Pepose J.S., and Stuart P.M. Proinflammatory cytokines IL-1 and TNF-a are required for recurrent herpetic keratitis in NIH mice. Invest. Ophth. Vis. Sci. 41 (2000) 96-102
16. Keadle T.L., Usui N., Laycock K.A., Kumano Y., Pepose J.S., and Stuart P.M. Corneal cytokine expression in a murine model recurrent herpetic stromal keratitis. Ocular Immunol. Inflam. 9 (2001) 193-205
17. Keadle T.L., Morris J.L., Pepose J.S., and Stuart P.M. CD4+ and CD8+ cells are key participants in the development of recurrent herpetic stromal keratitis in mice. Microbial Path. 32 (2002) 255-262
18. Khanna K., Bonneau R., Kinchington P., and Hendricks R.L. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18 (2003) 593-603
19. Laycock K.A., Lee S.F., Brady R.H., and Pepose J.S. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B irradiation. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2741-2746
20. Lekstrom-Himes J.A., LeBlanc R.A., Pesnicak L., Godleski M., and Straus S.E. Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice. J Virol. 74 (2000) 6680-6683
21. Lee S., Zheng M., Deshpande S., Eo S.K., Hamilton T.A., and Rouse B.T. IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis. J. Leukoc. Biol. 71 (2002) 469-476
22. Liu T., Tang Q., and Hendricks R.L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70 (1996) 264-271
23. Liu T., Khanna K.M., Carriere B.N., and Hendricks R.L. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75 (2001) 11178-11184
24. Maertzdorf J., Osterhaus A.D., and Verjans G.M. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J. Immunol. 169 (2002) 5897-5903
25. Maertzdorf J., Verjans G.M., Remeijer L., van der Kooi A., and Osterhaus A.D. Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4+ and CD8+ herpes simplex virus-specific T cells in patients with herpetic stromal keratitis. J. Infect. Dis. 187 (2003) 550-558
26. Mikloska Z., and Cunningham A.L. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J. Virol. 75 (2001) 11821-11826
27. Miller J.K., Laycock K.A., Umphress J.A., Hook K.K., Stuart P.M., and Pepose J.S. A comparison of recurrent versus primary HSK in inbred mice. Cornea 15 (1996) 497-504
28. Niemialtowski M.G., and Rouse B.T. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149 (1992) 3035-3039
29. Osorio Y., Weschsler S.L., Nesburn A.B., and Ghiasi H. Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice. Virus Res. 90 (2002) 317-326
30. Pepose J.S., Leib D.A., Stuart P.M., and Easty D.L. Herpes simplex virus diseases: anterior segment of the eye. In: Peposes J.S., Holland G.A.N., and Wilhelmus K.R. (Eds). Ocular infection and immunity (1996), Mosby, St. Louis, Mo 905-932
31. Presti R.M., Pollock J.L., Dal Canto A.J., O'Guin A.K., and Virgin H.W. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188 (1998) 577-588
32. Rinne J.R., Abghari S.Z., and Stulting R.D. The severity of herpes simplex viral keratitis in mice does not reflect the severity of disease in humans. Invest. Ophthal. Vis. Sci. 33 (1992) 268-272
33. Smith P.M., Wolcott R.M., Chervenak R., and Jennings S.R. Control of acute cutaneous herpes simplex virus infection: T cell mediated viral clearance is dependent upon interferon-gamma. Virology 202 (1994) 76-88
34. Strand S.S., and Leib D.A. Role of the VP16-binding domain of vhs in viral growth, host shutoff activity, and pathogenesis. J. Virol. 78 (2004) 13562-13572
35. Streilein J.W., Dana M.R., and Ksander B.R. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol. Today 18 (1997) 443-449
36. Stumpf T.H., Shimeld C., Easty D.L., and Hill T.J. Cytokine production in a murine model of recurrent herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 42 (2001) 372-378
37. Stumpf T.H., Case R., Shimeld C., Easty D.L., and Hill T.J. Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids. J. Gen. Virol. 83 (2002) 1579-1590
38. Su Y.H., Yan X.T., Oakes J.E., and Lausch R.N. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J. Virol 70 (1996) 1277-1281
39. Theil D., Derfuss T., Paripovic I., Herberger S., Meinl E., Schueler O., Strupp M., Arbusow V., and Brandt T. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 163 (2003) 2179-2184
40. Thomas J., and Rouse B.T. Immunopathogenesis of herpetic ocular disease. Immunol. Res. 16 (1997) 375-386
41. Thomas J., Kanangat S., and Rouse B.T. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J. Interfer. Cyto. Res 18 (1998) 681-690
42. Vollstedt S., Arnold S., Schwerdel C., Franchini M., Alber G., Di Santo J.P., Ackermann M., and Suter M. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J. Virol. 78 (2004) 3846-3850
43. Xu M., Lepisto A.J., and Hendricks R.L. CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas. J. Immunol. 173 (2004) 1232-1239
44. Youinou P., Colin J., and Mottier D. Immunological analysis of the cornea in herpetic stromal keratitis. J. Clin. Lab. Immunol. 17 (1985) 105-106
45. Youinou P., Colin J., and Ferec C. Monoclonal antibody analysis of blood and cornea T lymphocyte subpopulations in herpes simplex keratitis. Graefes Arch. Clin. Exp. Ophthalmol. 224 (1986) 131-133